Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation

Vaccine

Volumn 17, Issue 20-21, 1999, Pages 2562-2568

  Griffiths, G D ^a   Phillips, G J ^a   Bailey, S C ^a  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; RICIN; TOXOID; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG FORMULATION; INFLAMMATION; INFLAMMATORY CELL; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; QUALITY CONTROL; RAT; TISSUE INJURY; VACCINATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; LEUKOCYTE COUNT; LIPOSOMES; NEUTROPHILS; PROTEINS; RATS; RATS, WISTAR; RICIN; TOXOIDS; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES;

EID: 0033523046     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00054-7     Document Type: Article

References (30)

1. Olsnes S., Pihl A. Toxic lectins and related proteins. Cohen P., van Heyningen S., Molecular action of toxins and viruses. 1982;51-105 Elsevier, Amsterdam.
2. Stirpe F., Barbieri L. Ribosome-inactivating proteins up to date. FEBS. 195:1986;1-8.
3. Stirpe F., Barbieri L., Battelli M.G., Soria M., Lappi D.A. Ribosome-inactivating proteins from plants; present status and future prospects. Biotechnol. 10:1993;405-412.
4. Griffiths G.D., Rice P., Allenby A.C., Bailey S.C., Upshall D.G. Inhalation toxicology and histopathology of ricin and abrin toxins. Inhal Toxicol. 7:1995;269-288.
5. Brown R.F.R., White D.E. Ultrastructure of rat lung following inhalation of ricin aerosol. Int J Exp Path. 78:1997;267-276.
6. Licastro F., Morini M.C., Bolognesi A., Stirpe F. Ricin induces the production of tumour necrosis factor and interleukin 1β by human peripheral blood mononuclear cells. Biochem J. 294:1993;517-520.
7. Oppenheim J.J., Rossio J.L., Gearing A.J.H., Clinical applications of cytokines; Role in pathogenesis, diagnosis and therapy. 1993;Oxford University Press, New York, Oxford.
8. Griffiths G.D., Lindsay C.D., Allenby A.C., Bailey S.C., Scawin J.W., Rice P., Upshall D.G. Protection against inhalation toxicity of ricin and abrin by immunisation. Hum & Exp Toxicol. 14:1995;155-164.
9. Griffiths G.D., Bailey S.C., Hambrook J.L., Keyte M., Jayasekera P., Miles J., Williamson E.D. Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin. Vaccine. 15:1997;1933-1939.
10. Griffiths G.D., Bailey S.C., Hambrook J.L., Keyte M.P. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine. 16:(5):1998;530-535.
11. Wales R., Chaddock J.A., Roberts L.M., Lord J.M. Addition of an ER retention signal to the ricin A chain increases the cytotoxicity of the holotoxin. Exp Cell Res. 203:(1):1992;1-4.
12. Siegel S., Castellan N.J. Non-Parametric Statistics for the Behavioural Sciences. 2nd ed. 1988;213 McGraw-Hill International.
13. Markers of Cellular and Biochemical Response, Ch. 6, pp. 105-132 in Biologic Markers in Pulmonary Toxicology. National Research Council (US) Subcommittee on Pulmonary Toxicology, National Academy of Sciences 1989 National Academy Press.
14. Gregoriadis G. Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. 41st Forum in Immunology. Res Immunol. 143:1992;1-13.
15. Szoka F.C. The macrophage as the principal antigen presenting cell for liposome-encapsulated antigen. 41st Forum in Immunology. Res Immunol. 140:1992;1-13.
16. Alving C.R. Liposomes as carriers of antigens and adjuvants. J Immunol Meth. 140:1991;1-13.
17. de Haan A., Geerligs H.J., Huchshorn J.P., van Scharrenburg A.M., Wilschut J. Mucosal immunoadjuvant activity of liposomes; induction of systemic IgG and secretory IgA in mice by intranasal immunization with an influenza subunit vaccine and coadministered liposomes. Vaccine. 13:1995;1320-1324.
18. de Haan A., Tomee J.F.C., Huchshorn J.P., Wilschut J. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine. 13:1995;1320-1324.
19. Baenziger J., Fiete D. Structural determinants of Ricinus communis agglutinin and toxin specificity for oligosaccharides. J Biol Chem. 254:1979;9795-9799.
20. Foxwell B.M.J., Donovan T.A., Thorpe P.E., Wilson G. The removal of carbohydrates from ricin with endoglycosidases H, F and D and α-mannosidases. Biochim Biophys Acta. 840:1985;193-203.
21. Magnusson S., Berg T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem J. 291:1993;749-755.
22. Simmons B.M., Stahl P.D., Russell J.H. Mannose receptor-mediated uptake of ricin toxin and ricin A chain by macrophages. J Biol Chem. 261:1986;7912-7920.
23. Broug-Holub E., Toews G.B., van Iwaarden J.F., Strieter R.M., Kunkel S.L., Paine R. 3rd, Standiford T.J. Alveolar macrophages are required for protective pulmonary defences in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival. Infect & Immun. 65:1997;1139-1146.
24. Bavari S., Walters D.M., Creasia D.A. Ricin and ricin B chain stimulate the release of tumor necrosis factor-alpha from alveolar macrophages. The Toxicologist. 12:1992;292.
25. Brandes M.E., Wahl S.M. Inflammatory cytokines: An overview Ch 3. Schook L.B., Laskin D.L., Xenobiotics and Inflammation. 1994;Academic Press.
26. Dinarello C.A. Inflammatory consequences of cytokines in infectious diseases Ch 5. Oppenheim J.J., Rossio J.L., Gearing J.H., Clinical Applications of Cytokines. Role in pathogenesis, diagnosis and therapy. 1993;Oxford University Press, New York & Oxford.
27. Hybertson B.M., Jepson E.K., Cho O.J., Clarke J.H., Lee Y.M., Repine J.E. TNF mediates lung leak but not neutrophil accumulation, in lungs of rats given IL-1 intratracheally. Am J Respir & Crit Care Medicine. 155:1997;1972-1976.
28. Weiss S.J. Tissue Destruction by Neutrophils. New Engl J Med. 320:1989;365-376.
29. Lehrer R.I., Ganz T., Selsted M.E., Babior B.M., Curnutte J.T. Neutrophils and Host Defense. UCLA Conference. Annals Int Med. 1988;127-142.
30. Vogel P., Rivera V.R., Pitt M.L., Poli M.A. Comparison of the pulmonary distribution and efficacy of antibodies given to mice by intratracheal instillation or aerosol inhalation. Lab Animal Sci. 46:1996;516-523.